What is the pen needles market size in 2023?

The pen needles market size is USD 3.4 Billion in 2023.

What is the CAGR for the pen needles market?

The pen needles market is expected to grow at a CAGR of 10.9% during 2024-2033.

What are the segments covered in the pen needles market report?

Market.US has segmented the Global pen needles Market Value (US$ Mn) Analysis by Region, 2023 market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product Type, market has been segmented into standard pen needles and safety pen needles. By Needle Length, market has been further divided into 5 mm, 6 mm, 8mm, 10 mm, and other needle length. By Therapy, market has been further divided into Insulin, Growth hormone, and Glucagon-like-Peptide-1 (GLP-1).

Who are the key players in the pen needles market?

Novo Nordisk A/S, Becton, Dickinson and Company, Terumo Corp., Owen Mumford Ltd., B. Braun Melsungen AG, HTL-STREFA, UltiMed Inc., Allison Medical Inc., Artsana S.p.A. Other Key Players are the key vendors in the Pen needles market.

Which region is more attractive for vendors in the pen needles market?

Europe is expected to account for the highest revenue share of 38.9% among the other regions and reached USD 1.4 billion for the year 2023. Therefore, the pen needles market in Europe is expected to garner significant business opportunities for the vendors during the forecast period.

What are the key markets for pen needles?

Key markets for pen needles are the U.S., Canada, the U.K., Germany, Japan, India, China, Brazil, Mexico, and South Africa.

Which segment has the largest share in the pen needles market?

In the pen needles market, vendors should focus on grabbing business opportunities from the 8 mm Needle length segment as it accounted for the largest market share in the base year.

Pen Needles Market Size, Share, Trends

Global Pen Needles Market Analysis By Product Type (Standard Pen Needles, Safety Pen Needles), By Needle Length (4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm), By Therapy (Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

- Get a FREE Sample -

Our Clients